argenx SE
XBRU:ARGX

Watchlist Manager
argenx SE Logo
argenx SE
XBRU:ARGX
Watchlist
Price: 510.8 EUR 0.55% Market Closed
Market Cap: 31.2B EUR
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+34%
Revenue
Forecast
+39%
Operating Income
Forecast
N/A
Net Income
Forecast
+28%

Wall Street
Price Targets

ARGX Price Targets Summary
argenx SE

Wall Street analysts forecast ARGX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ARGX is 686.38 EUR with a low forecast of 505 EUR and a high forecast of 794.85 EUR.

ARGX Lowest Forecast
Wall Street Target
505 EUR
1% Downside
ARGX Average Forecast
Wall Street Target
686.38 EUR
34% Upside
ARGX Highest Forecast
Wall Street Target
794.85 EUR
56% Upside
Lowest
Price Target
505 EUR
1% Downside
Average
Price Target
686.38 EUR
34% Upside
Highest
Price Target
794.85 EUR
56% Upside
argenx SE Competitors:
Price Targets
RYTM
Rhythm Pharmaceuticals Inc
29% Upside
FHTX
Foghorn Therapeutics Inc.
162% Upside
K
2162
KeyMed Biosciences Inc
33% Upside
688177
Bio-Thera Solutions Ltd
4% Downside
RYTM
Rhythm Pharmaceuticals Inc
29% Upside
FHTX
Foghorn Therapeutics Inc.
162% Upside
K
2162
KeyMed Biosciences Inc
33% Upside
688177
Bio-Thera Solutions Ltd
4% Downside
4593
Healios KK
12% Downside
300896
Imeik Technology Development Co Ltd
28% Upside
HALO
Halozyme Therapeutics Inc
34% Upside
IONS
Ionis Pharmaceuticals Inc
67% Upside

Revenue
Forecast

Revenue Estimate
argenx SE

For the last 1 year the compound annual growth rate for argenx SE's revenue is 79%. The projected CAGR for the next 3 years is 39%.

79%
Past Growth
39%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
argenx SE

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
argenx SE

The compound annual growth rate of argenx SE's net income for the next 3 years is 28%.

N/A
Past Growth
28%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
ARGX intrinsic value, competitors valuation, and company profile.
DCF Valuation
ARGX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ARGX stock valuation using valuation multiples.
Wall Street Estimates
ARGX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ARGX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ARGX's stock price target?
Price Target
686.38 EUR

According to Wall Street analysts, the average 1-year price target for ARGX is 686.38 EUR with a low forecast of 505 EUR and a high forecast of 794.85 EUR.

What is argenx SE's Revenue forecast?
Projected CAGR
39%

For the last 1 year the compound annual growth rate for argenx SE's revenue is 79%. The projected CAGR for the next 3 years is 39%.

What is argenx SE's Net Income forecast?
Projected CAGR
28%

The compound annual growth rate of argenx SE's net income for the next 3 years is 28%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 259,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.